Insulet Corp - SCHEDULE 13G/A Filing Analysis

This filing is an amendment (Amendment No. 14) to a previous filing, specifically a SCHEDULE 13G/A, concerning Insulet Corp. The reporting entity is The Vanguard Group, identified as an Investment Adviser (IA). The filing indicates that as of March 13, 2026, The Vanguard Group does not hold any shares or have any voting or dispositive power over Insulet Corp. securities, with ownership reported at 0%. This is attributed to an internal realignment within The Vanguard Group on January 12, 2026, where certain subsidiaries began reporting beneficial ownership separately. Consequently, The Vanguard Group, Inc. no longer reports beneficial ownership for securities held by these subsidiaries. The filing also notes that while The Vanguard Group, Inc. itself holds no shares, its associated entities, such as investment companies and managed accounts, have the right to receive dividends or proceeds from the sale of securities, but no single entity holds more than 5% interest.